However, both groups with GATA3 inactivation, whether by methylation, LOF mutations or deleterious CNA, are associated with a worse relapse prognosis compared to tumours in which GATA3 is expressed and not mutated, regardless of the specific inactivation mechanism. Here, GATA3 is linked to neoplasm.